Seiichiro Himeno Selected Research

Seiichiro Himeno Research Topics

Disease

17	Neoplasms (Cancer) 07/2022 - 12/2003
5	Body Weight (Weight, Body) 11/2018 - 07/2010
5	Hypertension (High Blood Pressure) 01/2017 - 03/2012
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 06/2013
4	Acute Promyelocytic Leukemia 03/2016 - 01/2006
3	Asthma (Bronchial Asthma) 07/2022 - 05/2020
3	Carcinogenesis 12/2019 - 01/2012
3	Leukemia 03/2016 - 01/2011
3	Arsenic Poisoning 05/2006 - 08/2005
2	Inflammation (Inflammations) 07/2022 - 01/2012
2	Airway Obstruction (Choking) 07/2022 - 05/2020
2	Insulin Resistance 10/2020 - 07/2010
2	Hyperglycemia 10/2020 - 06/2019
2	Nervous System Diseases (Neurological Disorders) 04/2020 - 07/2010
2	Atherosclerosis 09/2013 - 01/2011
2	Melanoma (Melanoma, Malignant) 01/2013 - 01/2013
2	Neoplasm Metastasis (Metastasis) 01/2013 - 01/2013
1	Congenital Disorders of Glycosylation 01/2022
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2020
1	Cognitive Dysfunction 10/2019
1	Glucose Intolerance 06/2019
1	Diabetes Mellitus 06/2019
1	Virus Diseases (Viral Diseases) 01/2019
1	Chronic Disease (Chronic Diseases) 11/2018
1	Skin Neoplasms (Skin Cancer) 06/2016
1	Vascular Diseases (Vascular Disease) 02/2015
1	Parkinson Disease (Parkinson's Disease) 04/2014
1	Neuroblastoma 04/2014
1	Proteinuria 01/2014
1	Parkinsonian Disorders (Parkinsonism) 01/2013
1	Cardiotoxicity 12/2011
1	Glioma (Gliomas) 12/2011
1	Liver Diseases (Liver Disease) 07/2011
1	Poisoning 12/2010
1	Weight Gain 12/2010
1	Obesity 07/2010
1	Hemorrhage 10/2009
1	Prostatic Neoplasms (Prostate Cancer) 04/2007
1	Hypoxia (Hypoxemia) 04/2007
1	Ulcer 01/2004
1	Fibrosarcoma 01/2004

Drug/Important Bio-Agent (IBA)

25	ArsenicIBA 07/2022 - 08/2005
7	arseniteIBA 01/2021 - 01/2006
4	Drinking WaterIBA 05/2020 - 06/2017
4	MetallothioneinIBA 01/2012 - 12/2003
4	Arsenicals (Arsenic Compounds)IBA 12/2011 - 10/2005
3	Biomarkers (Surrogate Marker)IBA 07/2022 - 01/2017
3	ManganeseIBA 04/2014 - 01/2013
2	ORALIT (ORS)IBA 07/2022 - 10/2020
2	CreatinineIBA 10/2020 - 01/2014
2	CadmiumIBA 05/2013 - 10/2009
2	6,6'- bis- O- (3- nonyldodecanoyl)- alpha,alpha'- trehaloseIBA 01/2013 - 01/2013
2	Cisplatin (Platino)FDA LinkGeneric 08/2007 - 12/2003
1	CytokinesIBA 07/2022
1	Extracellular Matrix ProteinsIBA 07/2022
1	PeriostinIBA 07/2022
1	Amino Acids FDA Link 01/2022
1	1,4- dihydro- 1- ethyl- 7- phenylpyrrol(1,2- a)- pyrimidine- 4- oneIBA 01/2022
1	Bronchodilator Agents (Bronchodilators)IBA 05/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2019
1	LipopolysaccharidesIBA 01/2019
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019
1	Poly I-CIBA 01/2019
1	Antimony Potassium TartrateIBA 11/2018
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2016
1	Myeloblastin (Proteinase 3)IBA 03/2016
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 12/2015
1	Uric Acid (Urate)IBA 11/2014
1	Cadmium Chloride (Cadmium Dichloride)IBA 05/2013
1	manganese chloride (manganese chloride, tetrahydrate)FDA Link 05/2013
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 01/2013
1	Endothelin-1 (Endothelin 1)IBA 03/2012
1	Arsenic Trioxide (Trisenox)FDA Link 12/2011
1	EnzymesIBA 07/2011
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2011
1	Messenger RNA (mRNA)IBA 01/2011
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2010
1	Environmental Pollutants (Pollutants, Environmental)IBA 12/2010
1	sodium arsenite (sodium metaarsenite)IBA 12/2010
1	PowdersIBA 12/2010
1	CholesterolIBA 07/2010
1	LipidsIBA 07/2010
1	LeptinIBA 07/2010
1	Selenious Acid (Selenite)IBA 12/2009
1	AgarIBA 12/2009
1	Matrix Metalloproteinases (MMPs)IBA 12/2009
1	zinc-binding protein (zinc binding protein)IBA 10/2009
1	Proteins (Proteins, Gene)FDA Link 10/2009
1	Dihydrotestosterone (Androstanolone)IBA 04/2007
1	AndrogensIBA 04/2007
1	Androgen Receptors (Androgen Receptor)IBA 04/2007
1	Prostate-Specific Antigen (Semenogelase)IBA 04/2007
1	Endocrine DisruptorsIBA 01/2006
1	Estrogens (Estrogen)FDA Link 01/2006
1	monomethylarsonic acid (MSMA)IBA 08/2005
1	Citric Acid (Citrate)FDA LinkGeneric 01/2004

Therapy/Procedure

2	Therapeutics 03/2016 - 05/2006
2	Oral Administration 12/2010 - 01/2004
1	Transcutaneous Electric Nerve Stimulation (TENS) 12/2010